Biodesix, Inc. Common Stock

BDSXNASDAQUSD
14.36 USD
0.00 (0.00%)🟢PRE MARKET (AS OF 06:28 PM EDT)
🟢Market: OPEN
Open?$14.43
High?$14.71
Low?$13.69
Prev. Close?$14.17
Volume?43.8K
Avg. Volume?76.1K
VWAP?$13.98
Rel. Volume?0.57x
Bid / Ask
Bid?$8.72 × 100
Ask?$16.46 × 100
Spread?$7.74
Midpoint?$12.59
Valuation & Ratios
Market Cap?143.2M
Shares Out?10.1M
Float?4.9M
Float %?49.2%
P/E Ratio?N/A
P/B Ratio?15.69
EPS?-$3.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Employees
334
Market Cap
143.2M
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2020-10-28
Address
919 WEST DILLON ROAD
LOUISVILLE, CO 80027
Phone: 303-417-0500
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.82Strong
Quick Ratio?2.82Strong
Cash Ratio?1.76Strong
Debt/Equity?5.09High
ValuationATTRACTIVELY VALUED
Score
83/100
P/E?
N/A
P/B?
15.69HIGH
P/S?
1.49CHEAP
P/FCF?
N/A
EV/EBITDA?
-8.5CHEAP
EV/Sales?
1.71CHEAP
Returns & Efficiency
ROE?
-350.0%WEAK
ROA?
-33.8%WEAK
Cash Flow & Enterprise
FCF?$-25103000
Enterprise Value?$164.2M
Fundamentals ratios updated end of day